Counseling Is Effective for Smoking Cessation in Head and Neck Cancer Patients—A Systematic Review and Meta-Analysis

Journal of Oral and Maxillofacial Surgery

Volumn 74, Issue 8, 2016, Pages 1687-1694

  Klemp, Ingrid ^a   Steffenssen, Mia ^a   Bakholdt, Vivi ^b   Thygesen, Torben ^b   Sørensen, Jens Ahm ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; VARENICLINE;

CANCER PATIENT; CLINICAL EFFECTIVENESS; COGNITIVE BEHAVIORAL THERAPY; HEAD AND NECK CANCER; HEALTH EDUCATION; HUMAN; INFORMATION PROCESSING; META ANALYSIS; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRACTICE GUIDELINE; PREDICTOR VARIABLE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; COUNSELING; HEAD AND NECK TUMOR;

COUNSELING; HEAD AND NECK NEOPLASMS; HUMANS; SMOKING CESSATION;

EID: 84961772435     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2016.02.003     Document Type: Review

References (54)

1. 1 Jemal, A., Bray, F., Center, M.M., et al. Global cancer statistics. CA Cancer J Clin, 61, 2011, 69.
2. 2 Andre, K., Schraub, S., Mercier, M., et al. Role of alcohol and tobacco in the aetiology of head and neck cancer: A case-control study in the Doubs region of France. Eur J Cancer B Oral Oncol, 31B, 1995, 301.
3. 3 Kerawala, C.J., Oral cancer, smoking and alcohol: The patients’ perspective. Br J Oral Maxillofac Surg, 37, 1999, 374.
4. 4 Llewellyn, C.D., Linklater, K., Bell, J., et al. An analysis of risk factors for oral cancer in young people: A case-control study. Oral Oncol, 40, 2004, 304.
5. 5 Charles, E., Dodgen, P., Nicotine Dependence: Understanding and Applying the Most Effective Treatment Interventions. 2005, American Psychological Association, Washington, DC.
6. 6 Browman, G.P., Wong, G., Hodson, I., et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med, 328, 1993, 159.
7. 7 Day, G.L., Blot, W.J., Shore, R.E., et al. Second cancers following oral and pharyngeal cancers: Role of tobacco and alcohol. J Natl Cancer Inst, 86, 1994, 131.
8. 8 Des Rochers, C., Dische, S., Saunders, M.I., The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol (R Coll Radiol), 4, 1992, 214.
9. 9 Vander Ark, W., DiNardo, L.J., Oliver, D.S., Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope, 107, 1997, 888.
10. 10 Stevens, M.H., Gardner, J.W., Parkin, J.L., et al. Head and neck cancer survival and life-style change. Arch Otolaryngol, 109, 1983, 746.
11. 11 Benninger, M.S., Gillen, J., Thieme, P., et al. Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope, 104, 1994, 294.
12. 12 Hiyama, T., Sato, T., Yoshino, K., et al. Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res, 83, 1992, 334.
13. 13 Khuri, F.R., Kim, E.S., Lee, J.J., et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the Head and Neck Retinoid Chemoprevention Trial. Cancer Epidemiol Biomarkers Prev, 10, 2001, 823.
14. 14 De Boer, M.F., Van den Borne, B., Pruyn, J.F., et al. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: Results of a 6-year longitudinal study. Cancer, 83, 1998, 2567.
15. 15 Deleyiannis, F.W., Thomas, D.B., Vaughan, T.L., et al. Alcoholism: Independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst, 88, 1996, 542.
16. 16 Fiore, M.C., US public health service clinical practice guideline: Treating tobacco use and dependence. Respir Care, 45, 2000, 1200.
17. 17 Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6:e1000097, 2009.
18. 18 Cochrane Collaboration: The Cochrane Collaboration's tool for assessing risk of bias. Available at: http://ohg.cochrane.org/sites/ohg.cochrane.org/files/uploads/Risk of bias assessment tool.pdf. Accessed November 1, 2015.
19. 19 Guyatt, G., Mead, M.O., Cook, D.J., User's Guides to the Medical Literature, a Manual for Evidence-Based Clinical Practice. 2008, American Medical Association, McGraw-Hill Companies, New York, NY.
20. 20 Slik oppsummerer vi forskning. Håndbok for nasjonalt kunnskapssenter for helsetjenesten, Nasjonalt kunnskapssenter for helsetjenesten [The Norwegian Knowledge Centre for the Health Services]. 2013, p. 70.
21. 21 NHMRC: Additional levels of evidence and grades for recommendations for developers of guidelines. Available at: http://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/stage_2_consultation_levels_and_grades.pdf. Accessed November 1, 2015.
22. 22 Schnoll, R.A., Rothman, R.L., Wielt, D.B., et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med, 30, 2005, 1.
23. 23 Cooley, M.E., Emmons, K.M., Haddad, R., et al. Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer, 117, 2011, 2961.
24. 24 Kashigar, A., Habbous, S., Eng, L., et al. Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients. Cancer, 119, 2013, 2701.
25. 25 Marron, M., Boffetta, P., Zhang, Z.F., et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol, 39, 2010, 182.
26. 26 Schnoll, R.A., Rothman, R.L., Newman, H., et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: Implications for the development of tobacco control programs for cancer patients. Psychooncology, 13, 2004, 346.
27. 27 Simmons, V.N., Litvin, E.B., Patel, R.D., et al. Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns, 77, 2009, 398.
28. 28 Simmons, V.N., Litvin, E.B., Jacobsen, P.B., et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer, 119, 2013, 1420.
29. 29 Chan, Y., Irish, J.C., Wood, S.J., et al. Smoking cessation in patients diagnosed with head and neck cancer. J Otolaryngol, 33, 2004, 75.
30. 30 Sharp, L., Smoking among head and neck cancer patients: what can nurses do?. ORL Head Neck Nurs, 24, 2006, 10.
31. 31 Tan, S.T., Rajpal, K., Mackinnon, C.A., Smoking cessation in patients undergoing treatment for head and neck cancer. N Z Med J, 124, 2011, 130.
32. 32 Duffy, S.A., Scheumann, A.L., Fowler, K.E., et al. Perceived difficulty quitting predicts enrollment in a smoking-cessation program for patients with head and neck cancer. Oncol Nurs Forum, 37, 2010, 349.
33. 33 Sharp, L., Tishelman, C., Smoking cessation for patients with head and neck cancer: A qualitative study of patients’ and nurses’ experiences in a nurse-led intervention. Cancer Nurs, 28, 2005, 226.
34. 34 Schnoll, R.A., Rothman, R.L., Lerman, C., et al. Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head Neck, 26, 2004, 278.
35. 35 Martinez, E., Tatum, K.L., Weber, D.M., et al. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer Causes Control, 20, 2009, 97.
36. 36 Schnoll, R.A., Zhang, B., Rue, M., et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: A trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol, 21, 2003, 355.
37. 37 Duffy, S.A., Ronis, D.L., Valenstein, M., et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev, 15, 2006, 2203.
38. 38 Poate, T.W., Warnakulasuriya, S., Effective management of smoking in an oral dysplasia clinic in London. Oral Dis, 12, 2006, 22.
39. 39 Hamadah, O., Hepburn, S., Thomson, P.J., Effects of active non-smoking programmes on smoking behaviour in oral precancer patients. Int J Oral Maxillofac Surg, 36, 2007, 706.
40. 40 Gosselin, M.H., Mahoney, M.C., Cummings, K.M., et al. Evaluation of an intervention to enhance the delivery of smoking cessation services to patients with cancer. J Cancer Educ, 26, 2011, 577.
41. 41 Sharp, L., Fagerström, K., Rutqvist, L.E., et al. Smoking cessation among patients with head and neck cancer: Cancer as a “teachable moment.”. Eur J Cancer Care (Engl), 17, 2008, 114.
42. 42 de Bruin-Visser, J.C., Ackerstaff, A.H., Rehorst, H., et al. Integration of a smoking cessation program in the treatment protocol for patients with head and neck and lung cancer. Eur Arch Otorhinolaryngol, 269, 2012, 659.
43. 43 Romans, S.E., McNoe, B.M., Herbison, G.P., et al. Cigarette smoking and psychiatric morbidity in women. Aust N Z J Psychiatry, 27, 1993, 399.
44. 44 Amodei, N., Elkin, B.B., Burge, S.K., et al. Psychiatric problems experienced by primary care patients who misuse alcohol. Int J Addict, 29, 1994, 609.
45. 45 Faul, F., Erdfelder, E., Lang, A.-G., et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods, 39, 2007, 175.
46. 46 Faul, F., Erdfelder, E., Buchner, A., et al. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods, 41, 2009, 1149.
47. 47 Rigotti, N., Clair, C., Munafò, M., et al. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev, 5, 2012, CD001837.
48. 48 Fiore, M.C., Treating Tobacco Use and Dependence: 2008 Update, Clinical Practice Guideline. 2008, US Department of Health and Human Services, Rockville, MD.
49. 49 Ascher, J.A., Cole, J.O., Colin, J.N., et al. Bupropion: A review of its mechanism of antidepressant activity. J Clin Psychiatry, 56, 1995, 395.
50. 50 Coe, J.W., Brooks, P.R., Vetelino, M.G., et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem, 48, 2005, 3474.
51. 51 Damaj, M.I., Carroll, F.I., Eaton, J.B., et al. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Mol Pharmacol, 66, 2004, 675.
52. 52 Cinciripini, P.M., Robinson, J.D., Karam-Hage, M., et al. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry, 70, 2013, 522.
53. 53 Wald, N.J., Idle, M., Boreham, J., Bailey, A., Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax, 36, 1981, 366.
54. 54 Warren, G.W., Arnold, S.M., Valentino, J.P., et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol, 103, 2012, 45.